Poltava State Medical University, Poltava, Ukraine.
Department of Genetic Diagnostics, Institute of Genetic and Regenerative Medicine, SI "M.D. Strazhesko National Scientific Center of the NAMS of Ukraine", Kyiv, Ukraine.
Mol Biol Rep. 2024 May 8;51(1):630. doi: 10.1007/s11033-024-09569-4.
The pro-inflammatory cytokine IL-1 plays an important role in severe COVID-19. A change in IL-1 production may be associated with a mutation in the IL1Β gene. Our study analyzed the impact of the IL1Β gene variants (rs1143634) on disease progression in patients with severe COVID-19 pneumonia, taking into account treatment strategies.
The study enrolled 117 patients with severe COVID-19 pneumonia. The IL1Β gene variants were identified using the polymerase chain reaction-restriction fragment length polymorphism method. In the group of patients, the following genotype frequencies were found based on the investigated rs1143634 variant of the IL1Β gene: CC-65.8%, CT-28.2%, and TT-6.0%. Our results showed that the group of patients with the T allele of the IL1Β gene had higher leukocyte counts (p = 0.040) and more pronounced lymphopenia (p = 0.007). It was determined that patients carrying the T allele stayed on ventilators significantly longer (p = 0.049) and required longer treatment with corticosteroids (p = 0.045).
Identifying variants of the IL1Β gene can be used as a predictive tool for assessing the severity of COVID-19 pneumonia and tailoring personalized treatment strategies. Further research with a larger patient cohort is required to validate these findings.
促炎细胞因子 IL-1 在严重 COVID-19 中发挥重要作用。IL-1 产生的变化可能与 IL1Β 基因的突变有关。我们的研究分析了严重 COVID-19 肺炎患者中 IL1Β 基因变异(rs1143634)对疾病进展的影响,同时考虑了治疗策略。
这项研究纳入了 117 名患有严重 COVID-19 肺炎的患者。使用聚合酶链反应-限制性片段长度多态性方法确定了 IL1Β 基因的变体。在患者组中,根据研究的 IL1Β 基因 rs1143634 变体,发现了以下基因型频率:CC-65.8%、CT-28.2%和 TT-6.0%。我们的结果表明,携带 IL1Β 基因 T 等位基因的患者白细胞计数更高(p=0.040),淋巴细胞减少更明显(p=0.007)。携带 T 等位基因的患者在呼吸机上停留的时间明显更长(p=0.049),需要更长时间的皮质类固醇治疗(p=0.045)。
鉴定 IL1Β 基因的变体可以作为评估 COVID-19 肺炎严重程度和制定个体化治疗策略的预测工具。需要更大的患者队列进行进一步研究来验证这些发现。